26,000 Falls may Have Been Prevented after GPs Used Prescribing Tech to Change Drugs for at Risk Patients

First DatabankGreater scrutiny in prescribing amongst elderly patients may have prevented 26,000 falls in a single year, according to new analysis by Kent Surrey Sussex Academic Health Science Network (KSS AHSN).

The review examined the benefits of healthcare professionals using a prescribing decision support technology to avoid risky prescription of anticholinergic drugs in elderly patients with dementia or a history of falls, that might then result in potential adverse side effects. These could include impaired cognitive function and further falls.

Undertaken by KSS AHSN, the analysis for 2019/20 calculated that 26,000 falls may have been prevented after it compared the many thousands of times primary care prescribers accepted messages presented through the OptimiseRx solution, against the assessed risk of a fall to patients in question.

The issue of falls in elderly people is a significant concern within the UK, especially at a time when hospitals are dealing with pressures of the coronavirus emergency. A third of elderly people in the UK are expected to suffer one fall a year, with half of those having two or more falls[1]. Currently hip fractures account for 1.8 million bed days nationally, costing the NHS £1.1 billion per year[2].

Ian Mylon, Head of Analytics Delivery, KSS AHSN, said: "Our initial analysis of specific messages presented to prescribers relating to anticholinergic drugs shows some potentially very positive outcomes for the management and reduction of a serious clinical issue for elderly people. It is an important step towards a full cost-benefit analysis to understand the holistic impact of the use of OptimiseRx on the healthcare system."

Anticholinergic drugs are commonly used to treat a range of conditions including irritable bowel syndrome, excessive drooling, and urinary incontinence. They do this by blocking the neurotransmitter acetylcholine which controls a wide range of functions, from digestion and blood pressure, to muscle function and memory and attention.

However, other drug classes including antidepressants, antipsychotics, and antihistamines can inadvertently affect the acetylcholine system and increase the "anticholinergic burden" for patients, leading to a higher risk of adverse effects, including blurred vision, constipation, dry mouth, disorientation and even delirium and falls.

The analysis, an economic benefit forecast, considered the impact from GPs and other prescribers accepting prescribing guidance messages presented through their clinical system by OptimiseRx, a prescribing decision support technology provided to thousands of GP practices by drug knowledge company FDB (First Databank).

The analysis also forecast millions of pounds in gross benefits for the NHS in specific areas it examined - including reductions in hip fractures, reduced A&E attendance related to falls and subsequent reductions in physio treatment for hip fractures.

OptimiseRx is a software solution local medicines optimisation teams can use to enable a message offering relevant local or national guidance to be presented to prescribers at the point of prescribing, when medications might be suboptimal for a patient or when a prescription requires additional actions, such as observations, tests, or a co-prescription. It supports healthcare professionals with patient specific messages through their existing clinical system relating to a huge range of medicines.

Currently, more than 65% of NHS commissioning bodies and thousands of GP practices use OptimiseRx to provide best practice prescribing guidance, covering an estimated 38 million patients.

Darren Nichols, managing director, FDB UK, said: "Having a fall is a traumatic experience for any patient, with a serious impact on their health and wellbeing and requiring wide health support, especially in the case of a fracture and subsequent recovery, which brings considerable cost to the NHS. Now more than ever at a time when people need to remain at home during the coronavirus crisis, we need to do everything we can to avoid adverse events that could potentially lead to avoidable hospital visits.

"The messages relayed through our system relating to anticholinergic burden are designed as a safeguard within primary care to avoid harmful impact from inappropriate and risky prescribing, and to guide GP practices. The analysis carried out by KSS AHSN demonstrates how prescribing alternatives for patients can make a difference. As we continue to work with CCGs, health boards and healthcare professionals to refine information presented, we hope that even more healthcare professionals will choose to act on OptimiseRx’s comprehensive range of best practice guidance messages to improve care even further."

The report into anticholinergic drugs, commissioned by FDB, is available on request.

About FDB

FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver valuable, useful, and differentiated solutions. We offer four decades of experience in transforming medical knowledge into actionable, targeted, and effective solutions that help improve patient safety, operational efficiency, and healthcare outcomes.

About FDB OptimiseRx

FDB OptimiseRx® is the leading medicines optimisation solution for primary care in the UK. OptimiseRx combines evidence-based best practice, safety and cost-effective prescribing messages, and delivers them in real time at the point of care during the prescribing workflow.

In use in more than 4,000 GP practices covering over 38m patients across the UK, OptimiseRx is the gold standard for prescribing decision support and medicines optimisation.

OptimiseRx is the only solution that delivers patient-specific prescribing guidance, integrated with prescribing workflows, supporting medicines optimisation at the point of care in EMIS Web, TPP SystmOne and Microtest Evolution. Tailored to the patient medical record, OptimiseRx takes into consideration current and previous medications, morbidities, observations and measurements to support prescribers to make the safest, most clinically appropriate prescribing decision.

1. NHS 2018 www.nhs.uk/conditions/Falls/
2. Public Health England, Updated January 2020 Falls: applying All Our Health

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...